LimFlow SA

With the cost of healthcare continually rising, it is essential to keep patients healthier and more independent. As such, reducing amputation rates is essential for the economics of the healthcare sector. Not only would lowering the limb amputation rate decrease medical spending, but it would also improve patient quality of life.

“Amputation and the loss of an ability to ambulate often changes living situations, family situations, and the ability of an individual to take care of themselves,” explains Dan Clair, MD Professor and Chair of the Department of Vascular Surgery at Vanderbilt University Medical Center, in an interview with Joe Mullings, Chairman of the Board of TMG360 Media. “There’s a huge cost to caring for these patients beyond that initial procedure.”

The goal of LimFlow SA’s technology and the percutaneous Deep Vein Arterialization procedure is to keep these patients functional and keep healthcare expenses low for society as a whole.

Watch the full interview with Dr. Clair, Dan Rose, and Joe Mullings here https://youtu.be/GJjklWEC328.

The Effects of Reducing Amputation Rates - Dan Clair, MD of Vanderbilt University Medical Center With the cost of healthcare continually rising, it is essential to keep patients healthier and more independent. As such, reducing amputation rates is essent...

Steven K*m, MD, a vascular surgeon in the Department of Surgery at Changi General Hospital (CGH) in Singapore, has the distinction of being the vascular surgeon who performed the first-in-man LimFlow procedure.

For K*m, it was the close collaboration with the company and the relationship with Tim—which allowed the collaborators to share ideas with a quick turnaround—that led to the development of the current LimFlow device—a MedTech innovation that revolutionized the percutaneous deep vein arterialization procedure.

“With the people of this company, together with a bit of luck and the grace of our patients, we were able to find a solution and end up where we are right now,” said K*m.

Learn more about LimFlow SA’s growth from incubator idea to leading MedTech innovator here: https://youtu.be/V5eBNwMznNQ.

A Team of Collaborators - Steven K*m, MD, Vascular Surgeon at Changi General Hospital in Singapore Steven K*m, MD, a vascular surgeon in the Department of Surgery at Changi General Hospital in Singapore, has the distinction of being the vascular surgeon wh...

“Venous arterialization is a mechanism allowing us to deliver oxygenated blood flow to the feet through the venous system. Normally, when we do revascularization, what we’re trying to do is to restore blood flow through the arteries, but these patients have no arteries in their feet to deliver oxygen to the capillaries,” explained Daniel Clair, MD, Professor and Chair of the Department of Vascular Surgery at Vanderbilt University Medical Center in an interview with LimFlow SA CEO Dan Rose.

“What we’re doing in this situation is using the veins, which normally carry blood flow from the foot up to the heart, using those veins to carry blood flow into the foot.”

In the interview, Dr. Clair further explained how he was especially interested in LimFlow’s procedure as a solution because these patients have no other medical options left to save their limbs, and their risk of amputation is extremely high.

Patients in the PROMISE I study were adjudicated by an independent group of vascular surgeons to have no option for further surgical or endovascular intervention and were at risk of lower limb amputation prior to the deep vein arterialization procedure.

Watch the full clip with Dr. Clair, Dan Rose, and Joe Mullings, Chairman of the Board of TMG360 Media, here https://youtu.be/5E5D_onq-ws.

Restoring Blood Flow to the Feet - Daniel Clair, MD, Vanderbilt University Medical Center “Venous arterialization is a mechanism allowing us to deliver oxygenated blood flow to the feet through the venous system. Normally, when we do revasculariza...